Morgan BP - Search Results

1

CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanisms.

Longhi MP, Williams A, Wise M, Morgan BP, Gallimore A. Longhi MP, et al. Among authors: morgan bp. Eur J Immunol. 2007 May;37(5):1266-74. doi: 10.1002/eji.200636755. Eur J Immunol. 2007. PMID: 17429844 Free PMC article.

2

Complement: central to innate immunity and bridging to adaptive responses.

Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM. Morgan BP, et al. Immunol Lett. 2005 Mar 15;97(2):171-9. doi: 10.1016/j.imlet.2004.11.010. Epub 2004 Dec 7. Immunol Lett. 2005. PMID: 15752555 Review.

3

Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner.

Longhi MP, Sivasankar B, Omidvar N, Morgan BP, Gallimore A. Longhi MP, et al. Among authors: morgan bp. J Immunol. 2005 Dec 1;175(11):7098-102. doi: 10.4049/jimmunol.175.11.7098. J Immunol. 2005. PMID: 16301611 Free PMC article.

4

Holding T cells in check--a new role for complement regulators?

Longhi MP, Harris CL, Morgan BP, Gallimore A. Longhi MP, et al. Among authors: morgan bp. Trends Immunol. 2006 Feb;27(2):102-8. doi: 10.1016/j.it.2005.12.008. Epub 2006 Jan 10. Trends Immunol. 2006. PMID: 16406700 Review.

5

CD59a deficient mice display reduced B cell activity and antibody production in response to T-dependent antigens.

Sivasankar B, Donev RM, Longhi MP, Hughes TR, Davies R, Cole DS, Morgan BP, Marchbank KJ. Sivasankar B, et al. Among authors: morgan bp. Mol Immunol. 2007 Apr;44(11):2978-87. doi: 10.1016/j.molimm.2006.12.025. Epub 2007 Feb 12. Mol Immunol. 2007. PMID: 17296227

6

CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?

Sivasankar B, Longhi MP, Gallagher KM, Betts GJ, Morgan BP, Godkin AJ, Gallimore AM. Sivasankar B, et al. Among authors: morgan bp. J Immunol. 2009 May 1;182(9):5203-7. doi: 10.4049/jimmunol.0804243. J Immunol. 2009. PMID: 19380765 Free PMC article.

7

Complement-induced protection: an explanation for the limitations of cell-based tumour immunotherapies.

Kempshall E, Thebault S, Morgan BP, Harris CL, Gallimore A. Kempshall E, et al. Among authors: morgan bp. Immunol Cell Biol. 2012 Oct;90(9):869-71. doi: 10.1038/icb.2012.30. Epub 2012 Jul 10. Immunol Cell Biol. 2012. PMID: 22777521

8

Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity.

Omidvar N, Wang EC, Brennan P, Longhi MP, Smith RA, Morgan BP. Omidvar N, et al. Among authors: morgan bp. J Immunol. 2006 Mar 1;176(5):2915-23. doi: 10.4049/jimmunol.176.5.2915. J Immunol. 2006. PMID: 16493049 Free PMC article.

9

Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivo.

Hepburn NJ, Chamberlain-Banoub JL, Williams AS, Morgan BP, Harris CL. Hepburn NJ, et al. Among authors: morgan bp. Mol Immunol. 2008 Jan;45(2):395-405. doi: 10.1016/j.molimm.2007.06.144. Epub 2007 Jul 24. Mol Immunol. 2008. PMID: 17651804 Free PMC article.

10

Deletion of the membrane complement inhibitor CD59a drives age and gender-dependent alterations to bone phenotype in mice.

Bloom AC, Collins FL, Van't Hof RJ, Ryan ES, Jones E, Hughes TR, Morgan BP, Erlandsson M, Bokarewa M, Aeschlimann D, Evans BAJ, Williams AS. Bloom AC, et al. Among authors: morgan bp. Bone. 2016 Mar;84:253-261. doi: 10.1016/j.bone.2015.12.014. Epub 2015 Dec 22. Bone. 2016. PMID: 26721735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters